Assessing the Safety of Mechanically Fibrillated Cellulose Nanofibers (fib-CNF) via Toxicity Tests on Mice: Single Intratracheal Administration and 28 Days' Oral Intake.
Yoshihiro YamashitaAkinori TokunagaKoji AokiTamotsu IshizukaHideyuki UematsuHiroaki SakamotoSatoshi FujitaShuichi TanouePublished in: Toxics (2024)
Mechanically fibrillated cellulose nanofibers, known as fib-CNF (fiber length: 500 nm; diameter: 45 nm), are used in composites and as a natural thickener in foods. To evaluate their safety, we conducted a 28-day study in mice with inhalation exposure at 0.2 mg/body and oral administration of 400 mg/kg/day. Inhalation exposure to fib-CNF caused transient weight loss, changes in blood cell counts, and increased lung weights. These changes were attributed to adaptive responses. The oral administration of fib-CNF for 28 days resulted in no apparent toxic effects except for a slight decrease in platelet counts. The fib-CNF administration using the protocols studied appears to be safe in mice.
Keyphrases
- liver fibrosis
- high fat diet induced
- weight loss
- bariatric surgery
- oxidative stress
- single cell
- peripheral blood
- type diabetes
- wild type
- cell therapy
- magnetic resonance
- physical activity
- roux en y gastric bypass
- cerebral ischemia
- gastric bypass
- optic nerve
- silver nanoparticles
- reduced graphene oxide
- diffusion weighted imaging
- solid state